Marjoleen Nijsen

This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc.. Active years: 2013-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marjoleen Nijsen. Retrieved from https://idiyas.com/inventor/marjoleen-nijsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 12(Granted Patents)

Location History:

Abbott Park, IL (US) (2013 - 2015)
Wiesbaden, DE (2015)
North Chicago, IL (US) (2015)
Ludwigshafen, DE (2016 - 2018)

Company Filing History:

6 out of 167

Abbvie Deutschland Gmbh and Co Kg

where one patent can have more than one assignee

Years Active: 2013-2018

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10100048 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2018-10-16),

2. 9266855 - Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors (2016-02-23),

3. 9150545 - Carboxamide compounds and their use as calpain inhibitors V (2015-10-06),

4. 9062027 - Carboxamide compounds and their use as calpain inhibitors V (2015-06-23),

5. 9051304 - Carboxamide compounds and their use as calpain inhibitors V (2015-06-09),

6. 8598211 - Carboxamide compounds and their use as calpain inhibitors IV (2013-12-03),

Title: Marjoleen Nijsen: Innovator in Heterocyclic Compounds

Introduction

Marjoleen Nijsen is a prominent inventor based in Ludwigshafen, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic compounds. With a total of 6 patents to her name, her work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

One of her latest patents focuses on "Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors." This invention relates to novel heterocyclic compounds that are useful for inhibiting glycogen synthase kinase 3 (GSK-3). The patent details methods of making these compounds, compositions containing them, and methods of treatment utilizing these innovative compounds.

Career Highlights

Throughout her career, Marjoleen has worked with notable companies such as AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. Her experience in these organizations has allowed her to refine her expertise in drug development and patenting innovative solutions in the pharmaceutical industry.

Collaborations

Marjoleen has collaborated with esteemed colleagues, including Wilfried Hornberger and Andreas Kling. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Marjoleen Nijsen stands out as a dedicated inventor whose work in heterocyclic compounds showcases her commitment to advancing medical science. Her contributions are paving the way for new therapeutic options and highlight the importance of innovation in healthcare.

Profile summary based on public USPTO records.